Comparative performance of the new Aptima HIV-1 Quant Dx assay with three commercial PCR-based HIV-1 RNA quantitation assays

Journal of Clinical Virology

Volumn 69, Issue , 2015, Pages 56-62

  Hopkins, Mark ^a   Hau, Sarah ^a   Tiernan, Caroline ^b   Papadimitropoulos, Athanasios ^c   Chawla, Anu ^a   Beloukas, Apostolos ^c   Geretti, Anna Maria ^c  

^a Liverpool Genetics Laboratory   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Analytical performance; Aptima HIV 1 Quant Dx assay; HIV 1 quantitation; TMA; Viral load

Indexed keywords

VIRUS RNA; DIAGNOSTIC KIT;

ACCURACY; ARTICLE; COMPARATIVE STUDY; DILUTION; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VARIANCE; VIRUS DETECTION; VIRUS LOAD; BLOOD; DIAGNOSTIC KIT; EVALUATION STUDY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; NUCLEIC ACID AMPLIFICATION; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; VIROLOGY;

HIV INFECTIONS; HIV-1; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84937931811     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.05.020     Document Type: Article

References (37)

1. Williams I., Churchill D., Anderson J., et al. British HIV. Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (updated 11.13). HIV Med. 2014, 15:1-85. (Suppl. 1).
2. Asboe D., Aitken C., Boffito M., et al. British HIV. Association guidelines for the routine investigations and monitoring of adult HIV-1-infected individuals 2011. HIV Med. 2012, 13:1-44.
3. Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (updated 08.04.15). Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf.
4. Williams I., Churchill D., Anderson J., et al. British HIV. Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med. 2012, 13:1-85. (Suppl. 2).
5. European AIDS Clinical Society. Guidelines, version 7.1. Updated 11.14. Available at: http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html.
6. UK Standards for Microbiology Investigations, 2012. Anti-HIV Screening. UK Standards for Microbiology Investigations V11. 1-10.
7. Bourlet T., Signori-Schmuck A., Roche L., et al. HIV-1 load comparison using four commercial real-time assays. J. Clin. Microbiol. 2011, 49:292-297.
8. Church D., Gregson D., Lloyd T., et al. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1. 0, Easy Q v1. 2 and Versant assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. J. Clin. Microbiol. 2011, 49:118-124.
9. Garcia-Diaz A., Clewley G.S., Booth C.L., et al. Comparative evaluation of the performance of the abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for the measurement of HIV-1 plasma viral load following automated specimen preparation. J. Clin. Microbiol. 2006, 44:1788-1791.
10. Garcia-Diaz A., Labbett W., Clewley G.S., et al. Comparative evaluation of the artus HIV-1 QS-RGQ assay and the abbott realtime HIV-1 assay for the quantification of HIV-1 RNA in plasma. J. Clin. Virol. 2013, 57:66-69.
11. Schutten M., Peters D., Back N.K., et al. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J. Clin. Microbiol. 2007, 45:1712-1717.
12. Hill C.S. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Rev. Mol. Diagn. 2001, 1:445-455.
13. Giachetti C., Linnen J.M., Kolk D.P., et al. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J. Clin. Microbiol. 2002, 40:2408-2419.
14. Braun P., Ehret R., Wiesmann F., et al. Comparison of four commercial quantitative HIV-1 assays for VL monitoring in clinical daily routine. Clin. Chem. Lab. Med. 2007, 45:93-99.
15. Sauné K., Delaugerre C., Raymond S., et al. Analytical sensitivity of three real-time PCR assays for measuring subtype B HIV-1 RNA. J. Clin. Virol. 2013, 57:80-83.
16. Clinical Pathology Accreditation (UK) Ltd., 2010. Standards for the Medical Laboratory, version 2.02. Clinical Pathology Accreditation (UK).
17. Hologic, Inc. Aptima HIV-1 Quant Dx assay [product information]. Available at: http://stage.hologic.com/products/clinical-diagnostics-and-blood-screening/assays-and-tests/Aptima-hiv-1-quant-dx-assay.
18. Abbott Molecular RealTime HIV-1 [product information]. Available at: http://www.abbottmolecular.com/products/infectious-diseases/realtime-pcr/hiv-1-assay.html.
19. Qiagen GmbH. ARTUS® HI Virus-1 RG RT-PCR Kit Handbook (01.11). Available at: http://www.EN-artus-HI-virus-1-RG-RT-PCR-Kit-Handbook.pdf.
20. [20] Roche Molecular Diagnostics. COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0. [product information]. Available at: http://molecular.roche.com/assays/Pages/COBASAmpliPrepCOBASTaqManHIV-1Testv20.aspx.
21. QCMD, 2012. Human Immunodeficiency Virus A 2012 EQA Programme Final Report QAV994108 (HIVRNA12A). Glasgow, Scotland.
22. ® HIV-1, v2. 0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes. J. Clin. Virol. 2011, 52:181-186.
23. Garrett N.J., Apea V., Nori A., et al. Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1. 0 and 2. 0 and implications for patient management. J. Clin. Virol. 2012, 53:354-355.
24. Taylor N., Schmid I., Egle A., et al. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2. 0 assay for determining viral load in HIV-infected individuals. Antiviral Ther. (Lond.) 2009, 14:1189-1193.
25. Wojewoda C.M., Spahlinger T., Harmon M.L., et al. Comparison of Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads. J. Virol. Methods 2013, 187:1-5.
26. Glaubitz J., Sizmann D., Simon C.O., et al. Accuracy to 2nd international HIV-1 RNA who standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests. J. Clin. Virol. 2011, 50:119-124.
27. Paba P., Fabeni L., Ciccozzi M., et al. Performance evaluation of the COBAS/TaqMan HIV-1 v2. 0 in HIV-1 positive patients with low viral load: a comparative study. J. Virol. Methods 2011, 173:399-402.
28. Naeth G., Ehret R., Wiesmann F., et al. Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia. Med. Microbiol. Immunol. 2012, 202:67-75.
29. Taylor N., Grabmeier-Pfistershammer K., Egle A., et al. Cobas ampliprep/cobas TaqMan HIV-1 v2. 0 assay: consequences at the cohort level. PloS One 2013, 8:e74024.
30. Wall G.R., Perinpanathan D., Clark D.A. Comparison of the QIAGEN artus HIV-1 QS-RGQ test with the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v2. 0. J. Clin. Virol. 2012, 55:62-66.
31. Manak M., Hack H., Trsic T., et al. Evaluation of the Hologic Aptima HIV-1 Quant Dx assay with HIV-1 subtypes. Paper Presented at Conference on Retroviruses and Opportunistic Infections 2014, 620.
32. Ruelle J., Debaisieux L., Vancutsem E., et al. HIV-1 low-level viraemia assessed with 3 commercial real-time pcr assays show high variability. BMC Infect. Dis. 2012, 12:1-6.
33. Burd E.M. Validation of laboratory-developed molecular assays for infectious diseases. Clin. Microbiol. Rev. 2010, 23:550-576.
34. Doyle T., Smith C., Vitiello P., et al. Plasma HIV-1 RNA detection below 50copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin. Infect. Dis. 2012, 54:724-732.
35. Pas S., Rossen J.W.A., Schoener D., et al. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2. 0 for quantification of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 2010, 48:1195-1200.
36. Katoulidou A., Rokka C., Issaris C., et al. Comparative evaluation of the performance of abbott realtime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece. Virol. J. 2011, 8:1-11.
37. Fernandes H., Morosyuk S., Abravaya K., et al. Evaluation of effect of specimen-handling parameters for plasma preparation tubes on viral load measurements obtained by using the Abbott RealTime HIV-1 load assay. J. Clin. Microbiol. 2010, 48:2464-2468.